Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewClenbuterol
Discontinued Product
0688 has been discontinued.
View all Adrenergic β<sub>2</sub> Receptors products.
说明： b2 agonist
化学名： 4-Amino-a-[(tert-butylamino)methyl]-3,5-dichlorobenzylalcohol
生物活性 for Clenbuterol
β 2 agonist (Ki values are 60, 190 and 1100 nM for β 2, β 1 and β 3 receptors respectively). Bronchodilator, tocolytic.
技术数据 for Clenbuterol
| 分子量 | 277.19 |
| 储存 | Store at RT |
| CAS Number | 37148-27-9 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
产品说明书 for Clenbuterol
分析证书目前不在网上提供。
请联系客户服务
请联系客户服务
参考文献 for Clenbuterol
参考文献是支持产品生物活性的出版物。
Marin and Balfagon (1998) Effect of clenbu. on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of β-adrenoceptors. Br.J.Pharmacol. 124 473 PMID: 9647470
Strosberg and Pietri-Rouxel (1996) Function and regulation of the β3 adrenoceptor. TiPS 17 373 PMID: 8979772
Merck Index 12 2407
按产品操作查看相关产品
关键词: Clenbuterol, Clenbuterol supplier, Adrenergic, Beta-2, Receptors, 0688, Tocris Bioscience
Clenbuterol 的评论
目前没有该产品的评论。 Be the first to review Clenbuterol and earn rewards!
Have you used Clenbuterol?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
该领域的文献
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意，Tocris 仅会向正规科研企业/机构地址发送文献。
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.